Marilyne Debette-Gratien
Overview
Explore the profile of Marilyne Debette-Gratien including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
534
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carrier P, Woillard J, Debette-Gratien M, Loustaud-Ratti V
Dig Liver Dis
. 2025 Jan;
PMID: 39779434
No abstract available.
2.
Monchaud C, Woillard J, Crepin S, Tafzi N, Micallef L, Rerolle J, et al.
Transpl Int
. 2023 Aug;
36:11366.
PMID: 37588007
LCP-tacrolimus displays enhanced oral bioavailability compared to immediate-release (IR-) tacrolimus. The ENVARSWITCH study aimed to compare tacrolimus AUC in stable kidney (KTR) and liver transplant recipients (LTR) on IR-tacrolimus converted...
3.
Rose G, Tafzi N, El Balkhi S, Rerolle J, Debette-Gratien M, Marquet P, et al.
J Chromatogr B Analyt Technol Biomed Life Sci
. 2023 Apr;
1223:123721.
PMID: 37120962
Volumetric microsampling devices have been developed for home-based capillary blood sampling and are now increasingly proposed for the therapeutic drug monitoring (TDM) of immunosuppressive drugs. Our objective was to validate...
4.
Meunier L, Belkacemi M, Pageaux G, Radenne S, Vallet-Pichard A, Houssel-Debry P, et al.
Viruses
. 2023 Jan;
15(1).
PMID: 36680177
Background: Direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection have been proven safe and effective in cirrhotic patients awaiting liver transplantation (LT). However, in the...
5.
Debette-Gratien M, Francois S, Chevalier C, Alain S, Carrier P, Rigaud C, et al.
J Viral Hepat
. 2023 Jan;
30(4):355-361.
PMID: 36597183
According to the French recommendations, the elimination of the hepatitis C virus by 2025 could be a realistic public health goal. Screening policies are being intensified, and access to treatment...
6.
Carrier P, Destere A, Giguet B, Debette-Gratien M, Essig M, Monchaud C, et al.
World J Hepatol
. 2022 Sep;
14(8):1621-1632.
PMID: 36157874
Background: Renal failure is an independent prognostic factor for survival in patients with cirrhosis. Equations to calculate serum creatinine significantly overestimate the glomerular filtration rate (GFR). Plasma clearance of direct...
7.
Carrier P, Guyot A, Debette-Gratien M, Fredon F, Teissier M, Labrousse F, et al.
JGH Open
. 2021 Nov;
5(11):1316-1318.
PMID: 34816019
We report the case of a 36-year-old patient who was initially managed for gynecomastia. The first biological analyses showed a moderately elevated alpha-fetoprotein (AFP) level. After an endocrine etiology was...
8.
De Martin E, Coilly A, Chazouilleres O, Roux O, Peron J, Houssel-Debry P, et al.
J Hepatol
. 2021 Jan;
74(6):1325-1334.
PMID: 33503489
Background & Aims: In acute severe autoimmune hepatitis (AS-AIH), the optimal timing for liver transplantation (LT) remains controversial. The objectives of this study were to determine early predictive factors for...
9.
Brayette A, Essig M, Carrier P, Debette-Gratien M, Labrunie A, Alain S, et al.
World J Hepatol
. 2021 Jan;
12(12):1326-1340.
PMID: 33442458
Background: The recommended monitoring tools for evaluating nucleot(s)ide analogue renal toxicity, such as estimated glomerular filtration rate (eGFR) and phosphatemia, are late markers of proximal tubulopathy. Multiple early markers are...
10.
Loustaud-Ratti V, Anneraud A, Carrier P, Debette-Gratien M, De Muret A, Tallegas M, et al.
Hepatology
. 2020 Nov;
73(6):2615-2616.
PMID: 33185905
No abstract available.